Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	632,902	641,418	508,757	391,882	311,089	319,160
Market Cap Growth	-5.57%	26.07%	29.82%	25.97%	-2.53%	41.02%
Enterprise Value	579,794	582,946	446,243	344,587	277,190	290,055
Last Close Price	618.38	617.48	495.88	382.28	309.16	305.79
PE Ratio	32.31	-	28.97	22.31	23.84	22.66
PS Ratio	10.13	9.41	10.62	8.30	7.37	9.90
PB Ratio	6.86	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.52	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	35.59	-	31.42	18.89	23.18	20.53
P/OCF Ratio	31.94	-	29.64	17.95	21.12	18.89
EV/Sales Ratio	9.48	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	22.67	20.59	20.54	14.40	12.38	17.66
EV/EBIT Ratio	24.49	21.45	21.35	14.89	12.78	18.29
EV/FCF Ratio	32.60	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.11	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.37	0.37	0.18	0.20	0.24	0.30
Debt / FCF Ratio	0.55	-	0.24	0.23	0.40	0.32
Asset Turnover	0.50	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	4.10	5.31	7.38	8.87	8.97	10.62
Quick Ratio	1.84	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.36	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	22.31%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	12.04%	12.14%	13.17%	17.33%	19.32%	19.02%
Return on Invested Capital (ROIC)	29.76%	-98.60%	63.54%	90.72%	102.53%	89.76%
Return on Capital Employed (ROCE)	22.30%	23.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	3.09%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	2.81%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	-0.11%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.